We advise to exercise Vaxil Bio fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of Vaxil Bio as well as the relationship between them. We were able to interpolate twenty-five available drivers for Vaxil Bio, which can be compared to its competition. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Vaxil Bio to be traded at C$0.0099 in 90 days. Key indicators impacting Vaxil Bio's financial strength include:
Understanding current and past Vaxil Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vaxil Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Vaxil Bio's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Vaxil Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vaxil Bio. Check Vaxil Bio's Beneish M Score to see the likelihood of Vaxil Bio's management manipulating its earnings.
Vaxil Bio Stock Summary
Vaxil Bio Ltd., an immunotherapy biotech company, engages in the research and development of immunotherapies for cancer and infectious diseases in Israel. The company was founded in 2006 and is headquartered in Toronto, Canada. VAXIL BIO is traded on TSX Venture Exchange in Canada.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Vaxil Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Vaxil Stock, because this is throwing your money away. Analyzing the key information contained in Vaxil Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Vaxil Bio Key Financial Ratios
There are many critical financial ratios that Vaxil Bio's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vaxil Bio reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Vaxil Bio's current stock value. Our valuation model uses many indicators to compare Vaxil Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxil Bio competition to find correlations between indicators driving Vaxil Bio's intrinsic value. More Info.
Vaxil Bio is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . At this time, Vaxil Bio's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vaxil Bio's earnings, one of the primary drivers of an investment's value.
Vaxil Bio Systematic Risk
Vaxil Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vaxil Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Vaxil Bio correlated with the market. If Beta is less than 0 Vaxil Bio generally moves in the opposite direction as compared to the market. If Vaxil Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vaxil Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vaxil Bio is generally in the same direction as the market. If Beta > 1 Vaxil Bio moves generally in the same direction as, but more than the movement of the benchmark.
Vaxil Bio Total Assets Over Time
Today, most investors in Vaxil Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vaxil Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Vaxil Bio growth as a starting point in their analysis.
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.